Search Results - "Rajeh, Nabeel"
-
1
Therapy-Related Acute Promyelocytic Leukemia: A Case Report and a Review of Literature
Published in Curēus (Palo Alto, CA) (17-07-2023)“…Acute promyelocytic leukemia (APL) is a subgroup of acute myeloid leukemia (AML), and while not a common form of cancer, it does make up a modest portion of…”
Get full text
Journal Article -
2
Myasthenia Gravis Presenting as Graft versus Host Disease after Allogeneic Blood Stem Cell Transplant
Published in Case reports in hematology (01-01-2018)“…Myasthenia gravis is a very rare manifestation of graft versus host disease after stem cell transplants. Herein, we describe a case of new-onset myasthenia…”
Get full text
Journal Article -
3
Primary central nervous system Hodgkin Lymphoma: A case discussion and a hypothesis on the etiology
Published in Avicenna journal of medicine (01-01-2019)“…Abstract Hodgkin Lymphoma (HL) is a systemic disease with involvement of the cervical, supraclavicular, and mediastinal lymph nodes. It is commonly diagnosed…”
Get full text
Journal Article -
4
Primary Gastric ALK-negative EBV-negative Anaplastic Large Cell Lymphoma Presenting with Iron Deficiency Anemia
Published in In vivo (Athens) (01-07-2017)“…Anaplastic large cell lymphoma (ALCL) is a rare subtype of non-Hodgkin lymphoma (NHL). Primary gastric anaplastic lymphoma kinase (ALK) negative ALCL is…”
Get full text
Journal Article -
5
Surviving Stem Cell Transplantation Program In War Time In Syria
Published in Blood (15-11-2013)“…Substantial medical care deterioration occurred during Syrian civil war, including complete destruction of over 50 hospitals and 400 medical centers. We report…”
Get full text
Journal Article -
6
Diagnosis and Management of Acute Closed Angle Glaucoma after Autologous Hematopoietic Stem Cell Transplant
Published in Biology of blood and marrow transplantation (01-03-2016)Get full text
Journal Article -
7
Therapy-Related Acute Promyelocytic Leukemia: A Case Report and a Review of Literature
Published in Cureus (01-07-2023)Get full text
Report -
8
Phase II Study of Oral Rigosertib Combined with Azacitidine (AZA) As First Line Therapy in Patients (Pts) with Higher-Risk Myelodysplastic Syndromes (HR-MDS)
Published in Blood (13-11-2019)“…Background: AZA monotherapy has demonstrated improvement in OS in HR MDS, clinically meaningful and durable responses continue to be limited to a subset of…”
Get full text
Journal Article -
9
Phase 2 Expansion Study of Oral Rigosertib Combined with Azacitidine (AZA) in Patients (Pts) with Higher-Risk (HR) Myelodysplastic Syndromes (MDS): Efficacy and Safety Results in HMA Treatment Naïve & Relapsed (Rel)/Refractory (Ref) Patients
Published in Blood (29-11-2018)“…Background: AZA is first line therapy for pts with HR-MDS with an overall response rate (ORR) between 35 and 60% in various publications; with CR/PR rates…”
Get full text
Journal Article -
10
Myasthenia Gravis Presenting as Graft versus Host Disease after Allogeneic Blood Stem Cell Transplant
Published in Case reports in hematology (01-01-2018)Get full text
Report -
11
-
12
-
13
-
14
-
15
Primary central nervous system Hodgkin Lymphoma: A case discussion and a hypothesis on the etiology
Published in Avicenna journal of medicine (01-01-2019)Get full text
Report